Omni Bio Announces Progress of BioMimetix Pharmaceutical MarketWatch (press release) Novel discoveries made at the University of Colorado Denver indicate that AAT has the potential to address a variety of indications in the areas of diabetes, transplant rejection and bacterial and viral disorders. Omni Bio is a significant investor in ... |
